Publication Cover
Xenobiotica
the fate of foreign compounds in biological systems
Volume 31, 2001 - Issue 6
213
Views
46
CrossRef citations to date
0
Altmetric
Research Article

Carbamazepine: a 'blind' assessment of CYP-associated metabolism and interactions in human liver-derived in vitro systems

, , , , , , , , , , , , , , & show all
Pages 321-343 | Published online: 22 Sep 2008

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (13)

Brian G. Lake & Roger J. Price. (2013) Evaluation of the metabolism and hepatotoxicity of xenobiotics utilizing precision-cut slices. Xenobiotica 43:1, pages 41-53.
Read now
Yogita Ghodke Puranik, Angela K Birnbaum, Susan E Marino, Ghada Ahmed, James C Cloyd, Rory P Remmel, Ilo E Leppik & Jatinder K Lamba. (2013) Association of Carbamazepine Major Metabolism and Transport Pathway Gene Polymorphisms and Pharmacokinetics in Patients with Epilepsy. Pharmacogenomics 14:1, pages 35-45.
Read now
Gianpiero L Cavalleri, Mark McCormack, Saud Alhusaini, Elijah Chaila & Norman Delanty. (2011) Pharmacogenomics and Epilepsy: The Road Ahead. Pharmacogenomics 12:10, pages 1429-1447.
Read now
Sandeep Grover, Mandaville Gourie-Devi, Ruchi Baghel, Sangeeta Sharma, Kiran Bala, Meena Gupta, Krishnamoorthy Narayanasamy, Binuja Varma, Meenal Gupta, Kavita Kaur, Puneet Talwar, Harpreet Kaur, Sudheer Giddaluru, Abhay Sharma, Samir K Brahmachari, Indian Genome Variation Consortium & Ritushree Kukreti. (2010) Genetic Profile of Patients with Epilepsy on First-Line Antiepileptic Drugs and Potential Directions for Personalized Treatment. Pharmacogenomics 11:7, pages 927-941.
Read now
Shu-Feng Zhou, Bo Wang, Li-Ping Yang & Jun-Ping Liu. (2010) Structure, function, regulation and polymorphism and the clinical significance of human cytochrome P450 1A2. Drug Metabolism Reviews 42:2, pages 268-354.
Read now
María José Gómez-Lechón, José V Castell & María Teresa Donato. (2008) An update on metabolism studies using human hepatocytes in primary culture. Expert Opinion on Drug Metabolism & Toxicology 4:7, pages 837-854.
Read now
K. Venkatakrishnan, R. S. Obach & A. Rostami-Hodjegan. (2007) Mechanism-based inactivation of human cytochrome P450 enzymes: strategies for diagnosis and drug–drug interaction risk assessment. Xenobiotica 37:10-11, pages 1225-1256.
Read now
Kentaro Ueda, Takateru Ishitsu, Takayuki Seo, Nao Ueda, Tsukasa Murata, Masaharu Hori & Kazuko Nakagawa. (2007) Glutathione S-Transferase M1 Null Genotype as a Risk Factor for Carbamazepine-Induced Mild Hepatotoxicity. Pharmacogenomics 8:5, pages 435-442.
Read now
Juergen Friedrich, Reinhard Ebner & Leoni A. Kunz-Schughart. (2007) Experimental anti-tumor therapy in 3-D: Spheroids – old hat or new challenge?. International Journal of Radiation Biology 83:11-12, pages 849-871.
Read now
Olavi Pelkonen & Hannu Raunio. (2005) In vitro screening of drug metabolism during drug development: can we trust the predictions?. Expert Opinion on Drug Metabolism & Toxicology 1:1, pages 49-59.
Read now
Shufeng Zhou, Eli Chan, Wei Duan, Min Huang & Yu-Zong Chen. (2005) Drug Bioactivation Covalent Binding to Target Proteins and Toxicity Relevance. Drug Metabolism Reviews 37:1, pages 41-213.
Read now
Shufeng Zhou, Yihuai Gao, Wenqi Jiang, Min Huang, Anlong Xu & James W. Paxton. (2003) Interactions of Herbs with Cytochrome P450. Drug Metabolism Reviews 35:1, pages 35-98.
Read now

Articles from other publishers (33)

Friederike Kanefendt, André Dallmann, Huijun Chen, Klaus Francke, Tianxing Liu, Christine Brase, Sebastian Frechen & Marcus‐Hillert Schultze‐Mosgau. (2024) Assessment of the CYP3A4 Induction Potential by Carbamazepine: Insights from Two Clinical DDI Studies and PBPK Modeling. Clinical Pharmacology & Therapeutics 115:5, pages 1025-1032.
Crossref
Slobodan P. Rendic & F. Peter Guengerich. (2024) Formation of potentially toxic metabolites of drugs in reactions catalyzed by human drug-metabolizing enzymes. Archives of Toxicology.
Crossref
Jayaprakasam Bolleddula, Sathej Gopalakrishnan, Ping Hu, Jennifer Dong & Karthik Venkatakrishnan. (2022) Alternatives to rifampicin: A review and perspectives on the choice of strong CYP3A inducers for clinical drug–drug interaction studies . Clinical and Translational Science 15:9, pages 2075-2095.
Crossref
Laura Maria Fuhr, Fatima Zahra Marok, Nina Hanke, Dominik Selzer & Thorsten Lehr. (2021) Pharmacokinetics of the CYP3A4 and CYP2B6 Inducer Carbamazepine and Its Drug–Drug Interaction Potential: A Physiologically Based Pharmacokinetic Modeling Approach. Pharmaceutics 13:2, pages 270.
Crossref
N. A. Shnayder, E. N. Bochanova, D. V. Dmitrenko & R. F. Nasyrova. (2020) Pharmacogenetics of carbamazepine. Epilepsy and paroxysmal conditions 11:4, pages 364-378.
Crossref
Qiming Wu & Tsuyoshi Tsuduki. (2020) CYP4F13 is the Major Enzyme for Conversion of alpha-Eleostearic Acid into <i>cis</i>-9, <i>trans</i>-11-Conjugated Linoleic Acid in Mouse Hepatic Microsomes. Journal of Oleo Science 69:9, pages 1061-1075.
Crossref
Natasa Djordjevic, Slobodan M. Jankovic & Jasmina R. Milovanovic. (2017) Pharmacokinetics and Pharmacogenetics of Carbamazepine in Children. European Journal of Drug Metabolism and Pharmacokinetics 42:5, pages 729-744.
Crossref
Janne T. Backman, Anne M. Filppula, Mikko Niemi & Pertti J. Neuvonen. (2015) Role of Cytochrome P450 2C8 in Drug Metabolism and Interactions. Pharmacological Reviews 68:1, pages 168-241.
Crossref
Olavi Pelkonen. (2015) Drug Metabolism – From In Vitro to In Vivo , From Simple to Complex . Basic & Clinical Pharmacology & Toxicology 117:3, pages 147-155.
Crossref
Robert D. Pelletier, W. George Lai & Y. Nancy Wong. (2013) Application of a Substrate Cocktail Approach in the Assessment of Cytochrome P450 Induction Using Cultured Human Hepatocytes. SLAS Discovery 18:2, pages 199-210.
Crossref
Sheyla Ortiz de García, Gilberto Pinto Pinto, Pedro García Encina & Rubén Irusta Mata. (2013) Consumption and occurrence of pharmaceutical and personal care products in the aquatic environment in Spain. Science of The Total Environment 444, pages 451-465.
Crossref
Masaya Sakamoto, Tomoo Itoh & Ryoichi Fujiwara. (2013) Prediction of <i>in Vivo</i> Carbamazepine 10,11-Epoxidation from <i>in Vitro</i> Metabolic Studies with Human Liver Microsomes: Importance of Its Sigmoidal Kinetics. Biological and Pharmaceutical Bulletin 36:12, pages 1959-1963.
Crossref
Alexander V. LyubimovCostas Ioannides & Brian G. Lake. 2011. Encyclopedia of Drug Metabolism and Interactions. Encyclopedia of Drug Metabolism and Interactions 1 26 .
Hitomi Yuki, Teruki Honma, Masayuki Hata & Tyuji Hoshino. (2012) Prediction of sites of metabolism in a substrate molecule, instanced by carbamazepine oxidation by CYP3A4. Bioorganic & Medicinal Chemistry 20:2, pages 775-783.
Crossref
Yang Xu, Yihong Zhou, Mike Hayashi, Magang Shou & Gary L. Skiles. (2011) Simulation of Clinical Drug-Drug Interactions from Hepatocyte CYP3A4 Induction Data and Its Potential Utility in Trial Designs. Drug Metabolism and Disposition 39:7, pages 1139-1148.
Crossref
K. Schroeder, K.D. Bremm, N. Alépée, J.G.M. Bessems, B. Blaauboer, S.N. Boehn, C. Burek, S. Coecke, L. Gombau, N.J. Hewitt, J. Heylings, J. Huwyler, M. Jaeger, M. Jagelavicius, N. Jarrett, H. Ketelslegers, I. Kocina, J. Koester, J. Kreysa, R. Note, A. Poth, M. Radtke, V. Rogiers, J. Scheel, T. Schulz, H. Steinkellner, M. Toeroek, M. Whelan, P. Winkler & W. Diembeck. (2011) Report from the EPAA workshop: In vitro ADME in safety testing used by EPAA industry sectors. Toxicology in Vitro 25:3, pages 589-604.
Crossref
Olavi Pelkonen, Ari Tolonen, Miia Turpeinen & Jouko Uusitalo. 2010. Pharmaceutical Sciences Encyclopedia. Pharmaceutical Sciences Encyclopedia 1 32 .
Mohd Makmor-Bakry, Graeme J. Sills, Nikolas Hitiris, Elaine Butler, Elaine A. Wilson & Martin J. Brodie. (2009) Genetic Variants in Microsomal Epoxide Hydrolase Influence Carbamazepine Dosing. Clinical Neuropharmacology 32:4, pages 205-212.
Crossref
Thomas Nickl-Jockschat, Michael Paulzen, Frank Schneider & Michael Grözinger. (2009) Drug Interaction Can Lead to Undetectable Serum Concentrations of Quetiapine in the Presence of Carbamazepine. Clinical Neuropharmacology 32:1, pages 55.
Crossref
Jamie Henshall, Aleksandra Galetin, Anthony Harrison & J. Brian Houston. (2008) Comparative Analysis of CYP3A Heteroactivation by Steroid Hormones and Flavonoids in Different in Vitro Systems and Potential in Vivo Implications. Drug Metabolism and Disposition 36:7, pages 1332-1340.
Crossref
Su-Il Kang, Seo-Young Kang & Hor-Gil Hur. (2008) Identification of fungal metabolites of anticonvulsant drug carbamazepine. Applied Microbiology and Biotechnology 79:4.
Crossref
Ping Kang, Mingxiang Liao, Michael R. Wester, J. Steven Leeder, Robin E. Pearce & Maria Almira Correia. (2008) CYP3A4-Mediated Carbamazepine (CBZ) Metabolism: Formation of a Covalent CBZ-CYP3A4 Adduct and Alteration of the Enzyme Kinetic Profile. Drug Metabolism and Disposition 36:3, pages 490-499.
Crossref
Pietro Fagiolino, Marta Vázquez, Ivette Olano & Aurora Delfino. (2006) Systemic and presystemic conversion of carbamazepine to carbamazepine-10,11-epoxide during long term treatment. Journal of Epilepsy and Clinical Neurophysiology 12:1, pages 13-16.
Crossref
M.D. Tingle & N.A. Helsby. (2006) Can in vitro drug metabolism studies with human tissue replace in vivo animal studies?. Environmental Toxicology and Pharmacology 21:2, pages 184-190.
Crossref
Shufeng Zhou, Min Huang, Anlong Xu, Hongyuan Yang, Wei Duan & James W. Paxton. (2005) Prediction of herb–drug metabolic interactions: a simulation study. Phytotherapy Research 19:6, pages 464-471.
Crossref
Olavi Pelkonen, Miia Turpeinen, Jouko Uusitalo, Arja Rautio & Hannu Raunio. (2005) Prediction of Drug Metabolism and Interactions on the Basis of in vitro Investigations . Basic & Clinical Pharmacology & Toxicology 96:3, pages 167-175.
Crossref
Isabelle Ragueneau-Majlessi, Rene H. Levy, Donna Bergen, William Garnett, William Rosenfeld, Gary Mather, Jaymin Shah & John S. Grundy. (2004) Carbamazepine pharmacokinetics are not affected by zonisamide: in vitro mechanistic study and in vivo clinical study in epileptic patients. Epilepsy Research 62:1, pages 1-11.
Crossref
Shufeng ZhouEli ChanShen-Quan PanMin HuangEdmund Jon Deoon Lee. (2016) Pharmacokinetic Interactions of Drugs with St John’s Wort. Journal of Psychopharmacology 18:2, pages 262-276.
Crossref
Xavier Ponsoda, M. Teresa Donato, Gabriela Perez-Cataldo, Maria José Gómez-Lechón & José V. Castell. (2019) Drug Metabolism by Cultured Human Hepatocytes: How Far are we from the In Vivo Reality? . Alternatives to Laboratory Animals 32:2, pages 101-110.
Crossref
M. Teresa Donato & Jos?? V. Castell. (2003) Strategies and Molecular Probes to Investigate the Role of Cytochrome P450 in Drug Metabolism. Clinical Pharmacokinetics 42:2, pages 153-178.
Crossref
F Lakehal, C.J Wurden, T.F Kalhorn & R.H Levy. (2002) Carbamazepine and oxcarbazepine decrease phenytoin metabolism through inhibition of CYP2C19. Epilepsy Research 52:2, pages 79-83.
Crossref
Robin E. Pearce, Gangadhara R. Vakkalagadda & J. Steven Leeder. (2002) Pathways of Carbamazepine Bioactivation in Vitro I. Characterization of Human Cytochromes P450 Responsible for the Formation of 2- and 3-Hydroxylated Metabolites. Drug Metabolism and Disposition 30:11, pages 1170-1179.
Crossref
Pierre Kremers. (2003) In vitro Tests for Predicting Drug‐Drug Interactions: The Need for Validated Procedures . Pharmacology & Toxicology 91:5, pages 209-217.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.